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Diclofenac release from a silicon based contact lens material controlled by a chitosan/alginate coating
Release kinetics was investigated at 36ºC in sink
conditions using 3 mL of NaCl solution 130 mM
per sample. The drug quantification was done
using a UV-Vis spectrophotometer.
One Double layer was achieved by
formation of layers of Alginate
(crosslinked with CaCl2) and
Chitosan+Glyoxal.
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Eye drops are the most common form of ophthalmic treatment. However, these administration approach requires high drug doses which
may promote undesired systemic side effects [1, 2]. Contact lenses (CLs) have been subject to an increasing interest in the past few
years, being promoted as an advantageous ophthalmic therapeutic method. Their biocompatibility and prolonged contact with the eye
show their effective use as a drug delivery material [2]. Nevertheless, the majority of the loaded drug in the CLs tends to be released in an
initial burst.
In the present work surface modification by layer-by-layer (LbL) self-assembly process based in chitosan-alginate multilayers to control
the drug release from commercially available CLs materials (Definitive 50 from Contamac Products U.K.).
The drug release profile improved significantly due to the presence of the
chitosan/alginate layer: it allowed retarding the release almost 6 times,
leading to a controlled release for 3 days.
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Figure 1. Cumulative release profiles of diclofenac from the CLs uncoated and coated with Al-Ch LBL.
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 The drug release profile improved significantly due to the presence of the chitosan/alginate layer
 Retarding the release almost 6 times, leading to a controlled release for 3 days
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